These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Positron emission tomography measures of endogenous opioid neurotransmission and impulsiveness traits in humans. Love TM; Stohler CS; Zubieta JK Arch Gen Psychiatry; 2009 Oct; 66(10):1124-34. PubMed ID: 19805703 [TBL] [Abstract][Full Text] [Related]
11. Central μ-Opioidergic System Activation Evoked by Heavy and Severe-Intensity Cycling Exercise in Humans: a Pilot Study Using Positron Emission Tomography with 11C-Carfentanil. Hiura M; Sakata M; Ishii K; Toyohara J; Oda K; Nariai T; Ishiwata K Int J Sports Med; 2017 Jan; 38(1):19-26. PubMed ID: 28073122 [TBL] [Abstract][Full Text] [Related]
12. Time-course of change in [11C]carfentanil and [11C]raclopride binding potential after a nonpharmacological challenge. Scott DJ; Stohler CS; Koeppe RA; Zubieta JK Synapse; 2007 Sep; 61(9):707-14. PubMed ID: 17559096 [TBL] [Abstract][Full Text] [Related]
13. What to learn from in vivo opioidergic brain imaging? Sprenger T; Berthele A; Platzer S; Boecker H; Tölle TR Eur J Pain; 2005 Apr; 9(2):117-21. PubMed ID: 15737798 [TBL] [Abstract][Full Text] [Related]
14. Nicotine-specific and non-specific effects of cigarette smoking on endogenous opioid mechanisms. Nuechterlein EB; Ni L; Domino EF; Zubieta JK Prog Neuropsychopharmacol Biol Psychiatry; 2016 Aug; 69():69-77. PubMed ID: 27095017 [TBL] [Abstract][Full Text] [Related]
15. Placebo and nocebo effects are defined by opposite opioid and dopaminergic responses. Scott DJ; Stohler CS; Egnatuk CM; Wang H; Koeppe RA; Zubieta JK Arch Gen Psychiatry; 2008 Feb; 65(2):220-31. PubMed ID: 18250260 [TBL] [Abstract][Full Text] [Related]
16. Regional mu opioid receptor regulation of sensory and affective dimensions of pain. Zubieta JK; Smith YR; Bueller JA; Xu Y; Kilbourn MR; Jewett DM; Meyer CR; Koeppe RA; Stohler CS Science; 2001 Jul; 293(5528):311-5. PubMed ID: 11452128 [TBL] [Abstract][Full Text] [Related]
17. Alterations in endogenous opioid functional measures in chronic back pain. Martikainen IK; Peciña M; Love TM; Nuechterlein EB; Cummiford CM; Green CR; Harris RE; Stohler CS; Zubieta JK J Neurosci; 2013 Sep; 33(37):14729-37. PubMed ID: 24027273 [TBL] [Abstract][Full Text] [Related]
18. Opioid Release after High-Intensity Interval Training in Healthy Human Subjects. Saanijoki T; Tuominen L; Tuulari JJ; Nummenmaa L; Arponen E; Kalliokoski K; Hirvonen J Neuropsychopharmacology; 2018 Jan; 43(2):246-254. PubMed ID: 28722022 [TBL] [Abstract][Full Text] [Related]
19. Dynamic interactions between plasma IL-1 family cytokines and central endogenous opioid neurotransmitter function in humans. Prossin AR; Zalcman SS; Heitzeg MM; Koch AE; Campbell PL; Phan KL; Stohler CS; Zubieta JK Neuropsychopharmacology; 2015 Feb; 40(3):554-65. PubMed ID: 25139063 [TBL] [Abstract][Full Text] [Related]
20. Effects of placebo administration on immune mechanisms and relationships with central endogenous opioid neurotransmission. Prossin A; Koch A; Campbell P; Laumet G; Stohler CS; Dantzer R; Zubieta JK Mol Psychiatry; 2022 Feb; 27(2):831-839. PubMed ID: 34716408 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]